May 12, 2008 1:30 PM
- Text
New Drug Reverses Dentists' Anesthesia
Dentistry, Dentist, Dental, Teeth, Smile, Generic Image, RKF (CBS/AP)
(WebMD)
The FDA has approved OraVerse, the first drug indicated for reversing the effects of local anesthesia used by dentists.
According to Novalar Pharmaceuticals, the drug company that makes OraVerse, the FDA approved OraVerse's use in adults and children based on several clinical studies in which patients got an injection of OraVerse or a placebo after undergoing dental procedures under local anesthetics.
In the clinical studies, the patients who got OraVerse regained normal sensation in their lips faster than those who got the placebo. Within an hour after getting OraVerse, 41% of the patients had normal sensation in their lower lip, compared with 7% of those who got the placebo. And 59% of the OraVerse patients regained normal sensation in their upper lip within an hour after getting OraVerse, compared with 12% of those who got the placebo.
A Novalar news release states that no serious side effects were seen in the clinical studies; the most common side effect was pain at the injection site.
Novalar notes that although fast heart rate (tachycardia) and cardiac arrhythmia may occur when drugs like OraVerse are given intravenously, such problems are uncommon when OraVerse is injected into the gums.
OraVerse isn't recommended for use in children younger than 6 or children under 33 pounds.
By Miranda Hitti
Reviewed by Louise Chang
©2008 WebMD, LLC. All rights reserved
According to Novalar Pharmaceuticals, the drug company that makes OraVerse, the FDA approved OraVerse's use in adults and children based on several clinical studies in which patients got an injection of OraVerse or a placebo after undergoing dental procedures under local anesthetics.
In the clinical studies, the patients who got OraVerse regained normal sensation in their lips faster than those who got the placebo. Within an hour after getting OraVerse, 41% of the patients had normal sensation in their lower lip, compared with 7% of those who got the placebo. And 59% of the OraVerse patients regained normal sensation in their upper lip within an hour after getting OraVerse, compared with 12% of those who got the placebo.
A Novalar news release states that no serious side effects were seen in the clinical studies; the most common side effect was pain at the injection site.
Novalar notes that although fast heart rate (tachycardia) and cardiac arrhythmia may occur when drugs like OraVerse are given intravenously, such problems are uncommon when OraVerse is injected into the gums.
OraVerse isn't recommended for use in children younger than 6 or children under 33 pounds.
By Miranda Hitti
Reviewed by Louise Chang
©2008 WebMD, LLC. All rights reserved
Popular Now in Health
- Woman induces labor to let dying husband hold baby
- Overeating may double odds of memory loss in elderly
- Cancer drug reverses Alzheimer's in mice: Study
- 4.5 million Americans over 50 have artificial knees
- Skin cancer self-exam: What to look for (PHOTOS)
- Marijuana-smoking motorists twice as likely to crash
- Meet Adele's vocal cord surgeon, Dr. Steven Zeitels
- Things You Didn't Know About Your Penis
- HealthPop: Online dating and jaw engraving
- Whitney Houston back in rehab: Why?
- Christina Hendricks: Too Big for Hollywood?
- PICTURES: 15 Shocking Sexual Fetishes
- Jennifer Hudson: Is singer now too thin?
- Caffeine inhalers - the next club drug?
- John Dye Dies: What Killed "Angel" Star?
- Glen Campbell downplays Alzheimer's diagnosis
- Online dating downsides, romantic tattoo gone wrong: HealthPop Valentine's Day video
Latest CBS News Headlines
on Facebook
on CBS News
- N.D. education board sues to keep Fighting Sioux
- 17 to hospital after Calif. hotel chemical spill
- Summary Box: Empire State Building owner plans IPO
- Houston's body taken to airport for trip to NJ
on Facebook
- Whitney Houston 1963-2012
- Diane Aulger induces labor weeks early to let dying husband Mark hold baby
- 2012 Grammys: Red-carpet arrivals
on CBS News






